AIS
AMAG

AlphaOne Investment Services’s AMAG Pharmaceuticals AMAG Stock Holding History

AlphaOne Investment Services’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-66,105
Closed -$2.3M – 116
2016
Q4 		$2.3M Buy
66,105
+13,500
+26% +$403K 0.64% 74
2016
Q3 		$1.29M Sell
52,605
-2,409
-4% -$60.2K 0.42% 72
2016
Q2 		$1.32M Sell
55,014
-36,810
-40% -$844K 0.49% 71
2016
Q1 		$2.15M Buy
91,824
+5,007
+6% +$119K 0.88% 63
2015
Q4 		$2.62M Buy
86,817
+23,591
+37% +$762K 0.94% 60
2015
Q3 		$2.51M Sell
63,226
-37,965
-38% -$2.36M 1.07% 50
2015
Q2 		$6.99M Sell
101,191
-12,500
-11% -$786K 2.46% 4
2015
Q1 		$6.21M Sell
113,691
-47,806
-30% -$2.28M 2.33% 4
2014
Q4 		$6.88M Sell
161,497
-126,701
-44% -$4.58M 2.56% 3
2014
Q3 		$9.2M Buy
288,198
+190,750
+196% +$4.07M 2.95% 2
2014
Q2 		$2.02M Buy
+97,448
New +$1.8M 0.55% 69

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AlphaOne Investment Services's AMAG Position: Q1 2017 in Review

AlphaOne Investment Services sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 66,105 shares — an estimated $2.3M sold.

AlphaOne Investment Services first reported a position in AMAG in Q2 2014 and held it in 11 quarters. The position peaked at $9.2M in Q3 2014. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • AlphaOne Investment Services reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • AlphaOne Investment Services sold 66,105 AMAG Pharmaceuticals shares in Q1 2017, an estimated $2.3M.
  • AlphaOne Investment Services first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 11 quarters.
  • AlphaOne Investment Services's AMAG Pharmaceuticals position peaked at $9.2M in Q3 2014.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on AlphaOne Investment Services's 13F filing for Q1 2017, filed 9 May 2017.